The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Polen Capital bought shares 23 more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2021 and Q2 2022.
Regeneron has started 2025 with an increase in defensive capital allocation - initiation of a dividend and an expanded share buyback program. Increased compe...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Q4 2024 Earnings Conference Call February 4, 2025 8:30 AM ET Company Participants Ryan Crowe - SVP, IR Leonard...
Citadel Made More Than $4 Billion From Commodities In 2023 (Bloomberg) Pantera Capital Reveals $500 Billion Opportunity For Bitcoin (The Street) Jeffrey Epst...
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price boosted by equities research analysts at BMO Capital Markets from $1,055.00 to...